XML 41 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2014
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
In millions
Pharmacy
Services
Segment(1)
 
Retail
Pharmacy
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
March 31, 2014:
 
 
 
 
 
 
 
 
 
Net revenues
$
20,195

 
$
16,480

 
$

 
$
(3,986
)
 
$
32,689

Gross profit
934

 
5,184

 

 
(176
)
 
5,942

Operating profit (loss)
640

 
1,750

 
(190
)
 
(176
)
 
2,024

March 31, 2013:
 

 
 

 
 

 
 

 
 

Net revenues
18,311

 
16,039

 

 
(3,599
)
 
30,751

Gross profit
768

 
4,947

 

 
(138
)
 
5,577

Operating profit (loss)
499

 
1,532

 
(199
)
 
(138
)
 
1,694

Total assets:
 

 
 

 
 

 
 

 
 

March 31, 2014
40,365

 
30,960

 
2,480

 
(983
)
 
72,822

December 31, 2013
38,343

 
30,191

 
4,420

 
(1,428
)
 
71,526

Goodwill:
 

 
 

 
 

 
 

 
 

March 31, 2014
21,250

 
6,889

 

 

 
28,139

December 31, 2013
19,658

 
6,884

 

 

 
26,542


(1)          Net revenues of the Pharmacy Services Segment include approximately $2.2 billion of retail co-payments for both of the three months ended March 31, 2014 and 2013.
(2)        Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a stand-alone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment customers, through the Company’s intersegment activities (such as the Maintenance Choice® program), elect to pick-up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. The following amounts are eliminated in consolidation in connection with the item (ii) intersegment activity above: net revenues of $1.1 billion and $939 million for the three months ended March 31, 2014 and 2013, respectively; and gross profit and operating profit of $176 million and $138 million for the three months ended March 31, 2014 and 2013, respectively.